| 引用本文: | 刘园园,鱼洋,韩畅,杨洋,周京涛.基于肠道菌群多样性分析利伐沙班相关消化道出血的微生物组演变规律[J].中国现代应用药学,2026,43(19):13-21. |
| LIU Yuanyuan,YU Yang,HAN Chang,YANG Yang,ZHOU Jingtao.The evolution of the microbiome associated with rivaroxaban-related gastrointestinal bleeding was analyzed based on the diversity of intestinal flora[J].Chin J Mod Appl Pharm(中国现代应用药学),2026,43(19):13-21. |
|
| 摘要: |
| 目的 基于肠道菌群多样性分析,探讨利伐沙班引起消化道出血的微生物组演变规律及其潜在机制。方法 将24只雄性SD大鼠随机分为对照组和低、中、高剂量利伐沙班干预组,连续灌胃30 d后,采集胃内容物和十二指肠内容物,提取DNA并进行PacBio Sequel II全长16S rDNA测序,分析菌群结构、丰度及α、β多样性变化;同步检测凝血指标[凝血酶原时间(PT)、凝血酶时间(TT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(FIB)]并进行组织病理学检查;采用Spearman相关性分析探讨差异菌属与凝血参数及病理损伤的相关性。结果 利伐沙班干预可剂量依赖性地改变上消化道菌群结构,胃与十二指肠内容物菌群组间差异显著(R = 0.73,R = 0.79,P < 0.05)。属水平分析显示,Romboutsia、Lactobacillus、Ligilactobacillus、Streptococcus、Limosilactobacillus、Turicibacter、Allobaculum及Bacillus等菌群丰度发生显著变化(P < 0.05)。相关性分析表明,Bacillus和Ligilactobacillus与APTT、TT、PT呈显著正相关(P < 0.01)。Allobaculum和Limosilactobacillus则与上述指标及病理损伤评分(PR)呈负相关(P < 0.05)。病理检查可见中、高剂量组出现胃、十二指肠黏膜下层淤血、水肿及绒毛断裂。结论 利伐沙班可扰乱上消化道菌群生态,富集具有潜在促出血功能的菌属,同时耗竭保护性菌属,这种菌群结构的失衡可能与凝血功能异常及黏膜损伤协同作用,共同增加消化道出血风险。本研究为阐释利伐沙班相关出血机制提供了微生物学视角,也为临床评估抗凝治疗安全性提供了潜在生物标志物。 |
| 关键词: 利伐沙班 消化道菌群 出血 菌群多样性 关联性 |
| DOI: |
| 分类号: |
| 基金项目:自治区卫生健康青年医学科技人才专项科研项目(WJWY-202462) |
|
| The evolution of the microbiome associated with rivaroxaban-related gastrointestinal bleeding was analyzed based on the diversity of intestinal flora |
|
LIU Yuanyuan,YU Yang,HAN Chang,YANG Yang,ZHOU Jingtao
|
|
The Seventh Affiliated Hospital of Xinjiang Medical University
|
| Abstract: |
| OBJECTIVE To investigate the evolutionary patterns of the gut microbiome associated with rivaroxaban-induced gastrointestinal bleeding based on an analysis of intestinal flora diversity and to explore its underlying mechanisms. METHODS Twenty-four male Sprague-Dawley rats were randomly divided into a control group and low-, medium-, and high-dose rivaroxaban intervention groups. After 30 days of continuous intragastric administration, gastric and duodenal contents were collected. DNA was extracted and subjected to full-length 16S rDNA sequencing using PacBio Sequel II to analyze microbial community structure, abundance, and α/β diversity. Coagulation parameters - prothrombin time (PT), thrombin time (TT), activated partial thromboplastin time (APTT), and fibrinogen (FIB) - were measured, and histopathological examinations were performed. Spearman correlation analysis was used to explore relationships between differentially abundant genera and coagulation parameters/pathological injury. RESULTS Rivaroxaban intervention dose-dependently altered the upper gastrointestinal microbial structure, with significant differences in gastric and duodenal content communities between groups (R = 0.73 and R = 0.79, P < 0.05). At the genus level, significant abundance changes were observed in Romboutsia, Lactobacillus, Ligilactobacillus, Streptococcus, Limosilactobacillus, Turicibacter, Allobaculum and Bacillus (P < 0.05). Correlation analysis revealed that Bacillus and Ligilactobacillus were positively correlated with APTT, TT, and PT (P < 0.01), while Allobaculum and Limosilactobacillus were negatively correlated with these parameters and pathological injury scores (PR) (P < 0.05). Histopathological observations showed submucosal congestion, edema, and villous rupture in the medium- and high-dose groups. CONCLUSION Rivaroxaban disrupts the ecological balance of the upper gastrointestinal microbiota, enriching potentially bleeding-promoting genera while depleting protective genera. This structural imbalance in the microbiota may synergize with coagulation dysfunction and mucosal damage to collectively increase the risk of gastrointestinal bleeding. This study provides a microbiological perspective on the mechanism of rivaroxaban-associated bleeding and suggests potential biomarkers for evaluating the safety of anticoagulant therapy. |
| Key words: Rivaroxaban Gastrointestinal flora Bleeding Microbial community diversity Association |